[1]章斌.99Tcm-tetrofosmin在乳腺癌及其转移灶显像中的应用[J].国际放射医学核医学杂志,2001,25(1):12-15.
　ZHANG Bin.Application of 99Tcm-tetrofosmin scintigraphy in the diagnosis of breast cancer and metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(1):12-15.
点击复制

99Tcm-tetrofosmin在乳腺癌及其转移灶显像中的应用(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
25
期数:
2001年第1期
页码:
12-15
栏目:
综述
出版日期:
1900-01-01

文章信息/Info

Title:
Application of 99Tcm-tetrofosmin scintigraphy in the diagnosis of breast cancer and metastases
作者:
章斌
215006 江苏苏州, 苏州大学附属第一医院核医学科
Author(s):
ZHANG Bin
Department of Nuclear Medicine, First Affiliated Hospital of Suzhou University, Suzhou Jiangsu 215006, China
关键词:
乳腺癌; 99Tcm-tetrofosmin; 99Tcm-甲氧基异丁基异腈; 对比研究
Keywords:
99Tcm-tetrofosmin; breast cancer; 99Tcm-sestamibi; comparative study
分类号:
R817.4
摘要:
99Tcm-tetrofosm in作为亲肿瘤显像剂,对乳腺癌原发病灶和腋窝淋巴结转移的诊断有良好的灵敏度、特异性和准确率,可应用于乳腺癌全身骨转移和术后复发的诊断,其应用于乳腺癌前哨淋巴结转移的诊断、作为P-糖蛋白功能显像剂和三维立体定位引导孔针型活检等领域有着良好的发展前景。99Tcm-tetrofosm in乳腺癌及转移灶显像可与其他乳腺癌检查方法相结合提高乳腺癌诊断的准确率。
Abstract:
99Tcm-tetrofosmin as a positive indicator in oncology,99Tcm-tetrofosmin scintigraphy has high sensitivity,specificity and accuracy in diagnosis of primary breast cancer, of local recurrence and of axillary lymph node metastases.99Tcm-tetrofosmin can also be used to detect bone metastases and recurrence after surgery. Furthermore,99Tcm-tetrofosmin presents promising perspectives in sentinel lymph node detection and imaging, in function imag-ing of P-glycoprotein and in guiding a biopsy. Associated with other methods,99Tcm-tetrofosmin scintigraphy improves the accuracy of detecting breast cancer.

参考文献/References:

[1] Rambaldi PF,Mansi L,Procaini E,et al.Breast can-cer detestion with 99Tcm-tetrofosmin[J].Clin Nucl Med,1995,20:703-705.
[2] Mansi L,Rambaldi PF,Cuccurullo V,et al.Diagnos-tic and prognostic role of 99Tcm-tetrofosmin in breast cancer[J].Q J Nucl Med,1997,41:239-250.
[3] Arbab AS,Koizumi K,Toyama K,et al.Uptake of technetium-99m-tetrofosmin,technetium-99m-MIBI and thallium-201 in tumor cell lines[J].J Nucl Med,1996,37:1551-1556.
[4] De Jong M,Bernard BF,Breeman WAP,et al.Com-parison of uptake of 99Tcm-MIBI,99Tcm-tetrofosmin and 99Tcm-Q12 into human breast cancer cell lines[J].Eur JNucl M ed,1996,23:1361-1366.
[5] Ballinger JR,Bannerman J,Boxen I,et al.Tech-netium-99m-tetrofosmin as a substrate for P-glycopro-tein:in vitro studies in multidrugresistant breast tu-mor cells[J].J Nucl Med,1996,37:1578-1582.
[6] Higley B,Smith FW,Smith T,et al.Technetium-99m-1,2-bis[bis (2-ethoxyethyl) phosphino] ethane:hu-man biodistribution,dosimetry and safety of a new myocardial perfusion imaging agent[J].J Nucl Med,1993,34:30-38.
[7] Mansi L,Rambaldi PF,Procaccini E,et al.Scinti-mammography with technetium-99m-tetrofosmin in the diagnosis of breast cancer and lymph node metas-tases[J].Eur J Nucl Med,1996,23:932-939.
[8] Batista JF,Solano ME,Oliva JP,et al.Usefulness of 99Tcm-tetrofosmin scintimammography in palpable breast tumours[J].Nucl Med Commun,1997,18:338-340.
[9] Buscombe JR,Cwikla JB,Thakrar DS,et al.Prone SPET scintimammography[J].Nucl Med Commun,1999,20:237-245.
[10] Adalet I,Demirkol MO,Muslumanoglu M,et al.99Tcm-tetrofosmin scintigraphy in the evaluation of pal-pable breast masses[J].Nucl Med Commun,1997,18:118-121.
[11] Akcay MN,Akin Y,Karabag B,et al.99Tcm-tetrofos-min in breast carcinoma and axillary Iymph node metastases:a comparative study with 99Tcm-MIBI[J].Clin Nucl Med,1997,22:832-834.
[12] Takayame T,Kinuya S,Sugiyama M,et al.99Tcm-tetrofosmin scintimammography in palpable breast tu-mours[J].Ann Nucl Med,1998,12:293-296.
[13] Lacic M,Bokulic T,Lukac J,et al.Bone marrow im-munoscintigraphy for the detection of skeletal metas-tases in patients with breast cancer[J].Nucl Med Commun,1999,20:135-143.
[14] Keshtgar M RS,Ell PJ.Sentinel lymph node detection and imaging[J].Eur J Nucl Med,1999,26:57-67.
[15] Kabasakal L,Halac M,Nisli C,et al.The effect of P-glycoprotein function inhibition with cyclosporine A on the biodistribution of Tc-99m sestamibi[J].Clin Nucl Med,2000,25:20-23.
[16] Yutani K,Tatsumi M,Shiba E,et al.Comparison of dual-head coincidence gamma camera FDG PET in de-tection of breast cancer and axillary lymph node metas-tasis[J].JNucl Med,1999,40:1003-1008.
[17] Rostom AY,Powe J,Kandil A,et al.Positron emis-sion tomography in breast cancer:a clinico-pathologi-cal correlation of results[J].Br J Radiol,1999,72:1064-1068.
[18] Bleckmann C,Dose J,Bohuslavizki KH,et al.Effect of attenuation correction on lesion detectability in FDG PET of breast cancer[J].JNucl Med,1999,40:2021-2024.
[19] Amano S,Inoue T,Tomiyoshi K,et al.In vivo com-parison of PET and SPECT radiopharmaceuticals in detecting breast cancer[J].J Nucl Med,1998,39:1424-1427.
[20] Dehdashti F,Flanagan FL,Mortimer JE,et al.Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy[J].Eur J Nucl Med,1999,26:51-56.
[21] Fischer U,Kopka L,Grabbe E.Breast carcinoma:ef-fect of preoperative constrast-enhanced MR imaging on the therapeutic approach[J].Radiology,1999,213:881-888.
[22] Chen DR,Chang PF,Huang YL.Computer-aided di-agnosis applied to U S of solid breast nodules by using neural networks[J].Radiology,1999,213:407-412.
[23] Zonderland HM,Coerkamp E,Hermans J,et al.Di-agnosis of breast cancer of contribution of US as an ad-junct to mammography[J].Radiology,1999,213:413-422.

相似文献/References:

[1]张高潮,马丽,寇莹,等.99Tcm-tetrofosmin SPECT诊断肺部肿瘤的临床价值[J].国际放射医学核医学杂志,2015,39(4):303.[doi:10.3760/cma.j.issn.1673-4114.2015.04.007]
　Zhang Gaochao,Ma Li,Kou Ying,et al.Clinical value of 99Tcm-tetrofosmin SPECT in the diagnosis of lung neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):303.[doi:10.3760/cma.j.issn.1673-4114.2015.04.007]
[2]黎海涛.PET-CT在乳腺癌诊断中的应用价值[J].国际放射医学核医学杂志,2005,29(5):220.
　LI Hai-tao.The application value of PET-CT in the diagnosis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):220.
[3]李倩.钠/碘转运体的临床实用价值[J].国际放射医学核医学杂志,2003,27(2):56.
　LI Qian.Clinical value of sodium iodide symporter[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(1):56.
[4]宋进华.乳腺癌的基因治疗与核素靶向治疗[J].国际放射医学核医学杂志,2003,27(6):241.
　SONG Jin-hua.Gene therapy and radionuclides targeting therapy in mammary carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(1):241.
[5]何建华.99Tcm-MIBI用于乳腺癌诊断的评价[J].国际放射医学核医学杂志,2002,26(2):64.
　HE Jian-hua.Evaluation of 99Tcm-MIBI scintigraphy in the diagnosis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(1):64.
[6]程兵.99Tcm-MIBI显像检测乳腺癌多药耐药[J].国际放射医学核医学杂志,2002,26(2):67.
　CHENG Bing.The appliciation of 99Tcm-MIBI scintimammography to diagnose multidrug resistance of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(1):67.
[7]陈跃.前哨淋巴结显像研究[J].国际放射医学核医学杂志,2002,26(4):165.
　CHEN Yue.Detection of sentinel nodes by lymphoscintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(1):165.
[8]陈璟,吴华.乳腺癌前哨淋巴结探查的研究进展[J].国际放射医学核医学杂志,2002,26(5):222.
　CHEN Jing,WU Hua.Sentinel lymph node detection in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(1):222.
[9]陈立波.钠/碘同向转运体与放射性碘治疗[J].国际放射医学核医学杂志,2001,25(6):258.
　CHEN Li-bo.The sodium/iodide symporter and radioiodide therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(1):258.
[10]川玲,赵文锐.99Tcm-MIBI在检测乳腺癌中的作用[J].国际放射医学核医学杂志,2000,24(4):155.
　CHUAN Ling,ZHAO Wen-rui.The role of 99Tcm-sestamibi in breast cancer diagnosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(1):155.

备注/Memo

备注/Memo:
收稿日期:2000/6/13。
作者简介:章斌(1972-),男,江苏苏州人,苏州大学附属第一医院核医学科硕士研究生,主要从事肿瘤核医学研究。
更新日期/Last Update: 1900-01-01